X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4168) 4168
Publication (389) 389
Book Review (47) 47
Book Chapter (21) 21
Dissertation (17) 17
Conference Proceeding (10) 10
Government Document (2) 2
Magazine Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3005) 3005
her2 (2755) 2755
index medicus (2507) 2507
female (2429) 2429
oncology (2232) 2232
breast cancer (2075) 2075
trastuzumab (1429) 1429
cancer (1289) 1289
immunohistochemistry (1284) 1284
middle aged (1238) 1238
receptor, erbb-2 - metabolism (1173) 1173
gene amplification (1109) 1109
receptor, erbb-2 - genetics (1071) 1071
aged (1056) 1056
breast neoplasms - pathology (1011) 1011
adult (981) 981
breast neoplasms - genetics (890) 890
chemotherapy (858) 858
prognosis (838) 838
pathology (820) 820
breast neoplasms - metabolism (817) 817
expression (789) 789
breast neoplasms - drug therapy (757) 757
skin and connective tissue diseases (683) 683
epidermal growth factor (648) 648
in-situ hybridization (647) 647
amplification (644) 644
tumors (611) 611
male (590) 590
metastasis (588) 588
therapy (577) 577
research (570) 570
breast-cancer (551) 551
medicine & public health (542) 542
aged, 80 and over (538) 538
analysis (538) 538
carcinoma (531) 531
care and treatment (522) 522
in situ hybridization, fluorescence (513) 513
survival (487) 487
animals (486) 486
genetic aspects (469) 469
antineoplastic agents - therapeutic use (461) 461
cell line, tumor (455) 455
monoclonal-antibody (447) 447
gene expression (434) 434
overexpression (426) 426
erbb-2 protein (420) 420
adjuvant chemotherapy (377) 377
cell biology (377) 377
growth-factor receptor (375) 375
gene expression regulation, neoplastic (374) 374
neoplasms (371) 371
her2/neu (353) 353
treatment outcome (349) 349
gastric cancer (348) 348
receptor, erbb-2 - analysis (341) 341
egfr (333) 333
neoplasm staging (332) 332
biomarkers, tumor - metabolism (331) 331
proteins (331) 331
health aspects (324) 324
antibodies, monoclonal, humanized (322) 322
her-2/neu (319) 319
retrospective studies (319) 319
cancer therapies (311) 311
cancer research (310) 310
receptor (308) 308
medical prognosis (307) 307
biomarkers, tumor - genetics (304) 304
mice (298) 298
fish (294) 294
kinases (289) 289
mutation (284) 284
genes, erbb-2 (279) 279
receptor, erbb-2 - antagonists & inhibitors (277) 277
receptor, erbb-2 - biosynthesis (271) 271
biomarkers, tumor - analysis (266) 266
antineoplastic combined chemotherapy protocols - therapeutic use (265) 265
protein expression (264) 264
fluorescence in situ hybridization (260) 260
disease-free survival (258) 258
stomach cancer (252) 252
breast neoplasms - diagnosis (248) 248
development and progression (247) 247
erbb2 (243) 243
oncogene (239) 239
surgery (239) 239
antibodies, monoclonal - therapeutic use (238) 238
stomach neoplasms - pathology (234) 234
resistance (232) 232
article (231) 231
signal transduction (228) 228
lapatinib (226) 226
breast neoplasms - mortality (224) 224
biomarkers (221) 221
patients (221) 221
genes (219) 219
antineoplastic agents - pharmacology (216) 216
growth (216) 216
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4105) 4105
French (40) 40
Japanese (36) 36
German (22) 22
Korean (8) 8
Chinese (7) 7
Polish (5) 5
Spanish (5) 5
Russian (2) 2
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Histopathology, ISSN 0309-0167, 01/2019, Volume 74, Issue 2, pp. 300 - 310
Journal Article
Journal Article
BMC CANCER, ISSN 1471-2407, 01/2019, Volume 19, Issue 1, pp. 38 - 9
BackgroundHER2 (ERBB2 or HER2/neu) is a tyrosine-kinase increasing cell proliferation. Overexpression/amplification of HER2 is correlated with worse prognosis... 
Immunohistochemistry | Prognosis | GASTROESOPHAGEAL JUNCTION | TRASTUZUMAB | AMERICAN-PATHOLOGISTS | neu (ERBB2) | SOCIETY | GUIDELINE | Fluorescence-in-situ-hybridization (FISH) | BREAST-CANCER | HETEROGENEITY | ONCOLOGY | CHEMORADIATION | Esophageal adenocarcinoma (EAC) | Tissue microarray (TMA) | HER2 | BIOPSIES | Analysis | Genetic aspects | Research | Gene expression | Esophageal cancer | HER2/neu (ERBB2)
Journal Article
Journal Article
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 5, pp. 465.e1 - 465.e9
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 925 - 935
Journal Article
Journal Article